Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 32 entries
View as:

Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography

Phase: N/A Priority: Normal
NCT ID: NCT00704561 Org: User:
Start: 04/30/08 End: 10/31/09 Due: 10/31/10

Use of Viscoelastic Tests in the Treatment of Traumatic Induced Coagulopathy: a Pragmatic Randomized Clinical Trial.

Phase: N/A Priority: Normal
NCT ID: NCT03380767 Org: User:
Start: 12/31/19 End: 09/30/21 Due: 09/30/22

Long Term Treatment Interruptions

Phase: N/A Priority: Normal
NCT ID: NCT00433056 Org: User:
Start: 01/31/04 End: - Due: -

Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04346589 Org: User:
Start: 04/15/20 End: 10/27/22 Due: 10/27/23

Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03823365 Org: User:
Start: 12/17/18 End: 11/30/22 Due: 11/30/23

Optical Coherence Tomography in Long Lesions

Phase: N/A Priority: Normal
NCT ID: NCT01133925 Org: User:
Start: 05/31/08 End: 05/31/11 Due: 05/31/12

QoL and Adherence to One-pill Once-a-day HAART

Phase: N/A Priority: Normal
NCT ID: NCT00990600 Org: User:
Start: 04/30/08 End: 05/31/09 Due: 05/31/10

ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study

Phase: N/A Priority: Normal
NCT ID: NCT01798329 Org: User:
Start: 03/31/13 End: 09/30/15 Due: 09/30/16

Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.

Phase: N/A Priority: Normal
NCT ID: NCT00354822 Org: User:
Start: 08/31/05 End: 08/31/09 Due: 08/31/10

Cytokine Induced Killer (CIK) Cells In Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT01186809 Org: User:
Start: 07/31/09 End: 05/15/17 Due: 05/15/18

Safe Renal Function In Long Term Heart Transplanted Patients

Phase: N/A Priority: Normal
NCT ID: NCT00505102 Org: User:
Start: 01/31/07 End: 07/31/09 Due: 07/31/10

Cardiac Injury in COVID-19: a Pathology Study

Phase: N/A Priority: Normal
NCT ID: NCT04367792 Org: User:
Start: 04/23/20 End: 03/31/21 Due: 03/31/22

TRANSFORM OCT TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer With Optical Coherence Tomography

Phase: N/A Priority: Normal
NCT ID: NCT01972022 Org: User:
Start: 11/30/13 End: 09/30/16 Due: 09/30/17

Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial

Phase: N/A Priority: Normal
NCT ID: NCT02577965 Org: User:
Start: 03/31/11 End: 09/30/14 Due: 09/30/15

International Register of Open Abdomen

Phase: N/A Priority: Normal
NCT ID: NCT02382770 Org: User:
Start: 02/28/15 End: 12/31/18 Due: 12/31/19

Optical Coherence Tomography Following Paclitaxel Eluting Stent Implantation in Multivessel Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT00704145 Org: User:
Start: 11/30/07 End: 11/30/09 Due: 11/30/10

BASTA Study on STI in HIV Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00310245 Org: User:
Start: 11/30/00 End: 11/30/05 Due: 11/30/06

Bergamo Lymphoid Cancer Registry

Phase: N/A Priority: Normal
NCT ID: NCT03131531 Org: User:
Start: 03/23/17 End: 03/23/37 Due: 03/23/38

Prospective Study to Compare Results of STN-DBS Between Early Treated and Late-treated PD Patient

Phase: N/A Priority: Normal
NCT ID: NCT01274832 Org: User:
Start: 02/28/11 End: 09/30/14 Due: 09/30/15

Hypercoagulation Screening in Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02622815 Org: User:
Start: 04/30/12 End: 01/31/20 Due: 01/31/21

RPV+DRV/Cobi Dual Therapy in Subjects With HIV Controlled Infection

Phase: N/A Priority: Normal
NCT ID: NCT04064632 Org: User:
Start: 02/01/17 End: 11/30/19 Due: 11/30/20

Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01628380 Org: User:
Start: 06/30/12 End: 07/31/18 Due: 07/31/19

Fludarabine, Cyclophosphamide, Doxorubicin and Rituximab for the Treatment of Post-transplant Lymphoproliferative Disease (PTLD)

Phase: N/A Priority: Normal
NCT ID: NCT01088724 Org: User:
Start: 02/28/02 End: 03/31/10 Due: 03/31/11

Optical Coherence Tomography for Drug Eluting Stent Safety

Phase: N/A Priority: Normal
NCT ID: NCT00693030 Org: User:
Start: 08/31/06 End: 12/31/08 Due: 12/31/09

Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03821519 Org: User:
Start: 01/13/19 End: 05/31/23 Due: 05/31/24